Gene Symbol | Pearson Correlation Coefficient |
---|---|
MAPKAPK3 | 0.565 |
PDLIM3 | 0.549 |
PDLIM5 | 0.529 |
GATM | 0.523 |
TNS3 | 0.523 |
FAH | 0.522 |
SLC2A10 | 0.52 |
TSPAN12 | 0.519 |
A2ML1 | 0.519 |
MCC | 0.515 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
PKD2L1 | -0.464 |
RASGRP1 | -0.462 |
RXFP1 | -0.456 |
TRPV6 | -0.453 |
OCA2 | -0.45 |
ADTRP | -0.446 |
HS3ST2 | -0.444 |
RHO | -0.438 |
IGFBP2 | -0.43 |
NPBWR2 | -0.426 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB00010 | Sermorelin | BiotechDrug | 86168-78-7 | Approved|Withdrawn | Target |
DB08869 | Tesamorelin | Small Molecule | 218949-48-5 | Approved|Investigational | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in increased expression of GHRHR mRNA" | 20406850 |
D000082 | Acetaminophen | GHRHR gene mutant form results in decreased susceptibility to Acetaminophen | 17521389 |
D000082 | Acetaminophen | GHRHR protein affects the reaction [NR1I2 protein affects the susceptibility to Acetaminophen] | 17521389 |
D000082 | Acetaminophen | GHRHR protein affects the reaction [NR1I3 protein affects the susceptibility to Acetaminophen] | 17521389 |
D019386 | Alendronate | Alendronate affects the expression of GHRHR mRNA | 16079270 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of GHRHR mRNA | 16483693 |
D001280 | Atrazine | Atrazine binds to GHRHR protein | 20529762 |
D001280 | Atrazine | [Atrazine binds to GHRHR protein] which results in decreased expression of GH1 mRNA | 20529762 |
D004958 | Estradiol | [Estradiol binds to ESR2 protein] which results in increased expression of GHRHR mRNA | 20404318 |
D004958 | Estradiol | Estradiol results in increased expression of GHRHR protein | 16015026 |
C006780 | bisphenol A | bisphenol A results in decreased expression of GHRHR mRNA | 25181051 |
C032036 | bromobenzene | GHRHR gene mutant form results in decreased susceptibility to bromobenzene | 17521389 |
C018475 | butyraldehyde | butyraldehyde results in decreased expression of GHRHR mRNA | 26079696 |
D002251 | Carbon Tetrachloride | GHRHR gene mutant form results in increased susceptibility to Carbon Tetrachloride | 17521389 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of GHRHR mRNA | 25016146 |
D004052 | Diethylnitrosamine | GHRHR protein mutant form results in decreased susceptibility to Diethylnitrosamine | 11698349 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of GHRHR mRNA | 16079270 |
D005419 | Flavonoids | Flavonoids results in increased expression of GHRHR mRNA | 18035473 |
C501461 | MZ-J-7-118 | MZ-J-7-118 binds to and results in decreased activity of GHRHR protein | 18629632 |
D010758 | Phosphorus | Phosphorus results in decreased expression of GHRHR mRNA | 17715259 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride affects the expression of GHRHR mRNA | 16079270 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of GHRHR mRNA | 22298810 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of GHRHR mRNA | 22808131 |
D013849 | Thimerosal | Thimerosal results in increased expression of GHRHR mRNA | 24675092 |
C009495 | titanium dioxide | titanium dioxide results in decreased expression of GHRHR mRNA | 29128614 |
C057693 | troglitazone | troglitazone results in increased expression of GHRHR mRNA | 21515302 |
D015034 | Zinc Oxide | Zinc Oxide affects the expression of GHRHR mRNA | 28648595 |
D015049 | Zoxazolamine | GHRHR gene mutant form results in decreased susceptibility to Zoxazolamine | 17521389 |
D015049 | Zoxazolamine | GHRHR protein affects the reaction [NR1I3 protein affects the susceptibility to Zoxazolamine] | 17521389 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004930 | G-protein coupled receptor activity | - | IC | 7680413 |
GO:0005515 | protein binding | - | IPI | 1333056 7680413 |
GO:0008528 | G-protein coupled peptide receptor activity | - | IBA | 21873635 |
GO:0016520 | growth hormone-releasing hormone receptor activity | - | IBA | 21873635 |
GO:0016520 | growth hormone-releasing hormone receptor activity | - | IMP | 7680413 |
GO:0017046 | peptide hormone binding | - | IBA | 21873635 |
GO:0017046 | peptide hormone binding | - | IPI | 7680413 |
GO:0019838 | growth factor binding | - | IBA | 21873635 |
GO:0019838 | growth factor binding | - | IPI | 7680413 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0007166 | cell surface receptor signaling pathway | - | IEA | - |
GO:0007186 | G-protein coupled receptor signaling pathway | - | TAS | - |
GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway | - | IDA | 1333056 7680413 |
GO:0007190 | activation of adenylate cyclase activity | - | IEA | - |
GO:0007420 | brain development | - | IBA | 21873635 |
GO:0007595 | lactation | - | IEA | - |
GO:0008284 | positive regulation of cell proliferation | - | IBA | 21873635 |
GO:0008284 | positive regulation of cell proliferation | - | IDA | 12867592 |
GO:0008340 | determination of adult lifespan | - | IEA | - |
GO:0019933 | cAMP-mediated signaling | - | IMP | 7680413 |
GO:0030104 | water homeostasis | - | IEA | - |
GO:0030252 | growth hormone secretion | - | IEA | - |
GO:0032868 | response to insulin | - | IMP | 17356054 |
GO:0032869 | cellular response to insulin stimulus | - | IEA | - |
GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway | - | IEA | - |
GO:0040018 | positive regulation of multicellular organism growth | - | IMP | 8528260 |
GO:0042445 | hormone metabolic process | - | IEA | - |
GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway | - | NAS | 11773624 |
GO:0043627 | response to estrogen | - | IDA | 9482665 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | - | IEA | - |
GO:0048469 | cell maturation | - | IEA | - |
GO:0048609 | multicellular organismal reproductive process | - | NAS | 15944917 |
GO:0051246 | regulation of protein metabolic process | - | IEA | - |
GO:0051384 | response to glucocorticoid | - | IDA | 9482665 |
GO:0060124 | positive regulation of growth hormone secretion | - | NAS | 11773624 |
GO:0060133 | somatotropin secreting cell development | - | IEA | - |
GO:0071333 | cellular response to glucose stimulus | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005637 | nuclear inner membrane | - | IDA | 10461027 |
GO:0005640 | nuclear outer membrane | - | IDA | 10461027 |
GO:0005737 | cytoplasm | - | IDA | 10461027 |
GO:0005886 | plasma membrane | - | IDA | 10461027 |
GO:0005886 | plasma membrane | - | TAS | - |
GO:0009986 | cell surface | - | IDA | 1333056 |
GO:0016021 | integral component of membrane | - | IDA | 1333056 |
GO:0016363 | nuclear matrix | - | IDA | 10461027 |
GO:0030141 | secretory granule | - | IDA | 10461027 |
GO:0042383 | sarcolemma | - | IEA | - |
KEGG ID | KEGG Term |
---|---|
hsa04080 | Neuroactive ligand-receptor interaction |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-372790 | Signaling by GPCR | TAS |
R-HSA-373080 | Class B/2 (Secretin family receptors) | TAS |
R-HSA-388396 | GPCR downstream signalling | TAS |
R-HSA-418555 | G alpha (s) signalling events | TAS |
R-HSA-420092 | Glucagon-type ligand receptors | TAS |
R-HSA-500792 | GPCR ligand binding | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
22449891 | Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors. (2012 Jun) | Wong ML | Mol Psychiatry |
29797719 | Immunological and microbiological periodontal profiles in isolated growth hormone deficiency. (2018 May 25) | Araujo IMP | J Periodontol |